mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.01 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.02 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.02 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.02 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.02 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |